This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To evaluate the efficacy of subcutaneous and sublingual immunotherapy for type I latex allergy in reducing allergen sensitivity following latex exposure. To evaluate the safety of subcutaneous and sublingual immunotherapy for type I latex allergy.
CITATION STYLE
Makatsori, M., Durham, S., & Calderon, M. A. (2017, April 28). Specific immunotherapy for latex allergy. Cochrane Database of Systematic Reviews. John Wiley and Sons Ltd. https://doi.org/10.1002/14651858.CD009240.pub2
Mendeley helps you to discover research relevant for your work.